Sana Biotechnology, Inc.

SANA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$127,566$133,517$176,765$253,029
Short-Term Investments$24,931$71,678$247,198$297,967
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$8,311$8,320$20,474$7,105
Total Curr. Assets$160,808$213,515$444,437$558,101
Property Plant & Equip (Net)$135,269$145,592$159,403$161,784
Goodwill$140,627$140,627$140,627$140,627
Intangibles$59,195$59,195$59,195$59,195
Long-Term Investments$0$0$10,051$195,881
Tax Assets$0$0$0$0
Other NC Assets$5,121$6,370$9,007$13,819
Total NC Assets$340,212$351,784$378,283$571,306
Other Assets$0$0$0$0
Total Assets$501,020$565,299$822,720$1,129,407
Liabilities
Payables$5,210$4,108$2,857$2,219
Short-Term Debt$12,534$13,195$12,393$9,159
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$27,689$47,184$96,254$87,857
Total Curr. Liab.$45,433$64,487$111,504$99,235
LT Debt$81,663$90,901$95,860$101,784
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$123,420$122,405$116,041$199,886
Total NC Liab.$205,083$213,306$211,901$301,670
Other Liabilities$0$0$0$0
Cap. Leases$94,197$104,096$108,253$110,943
Total Liabilities$250,516$277,793$323,405$400,905
Equity
Pref Stock$0$0$0$0
Common Stock$22$20$19$18
Retained Earnings-$1,604,850-$1,338,091-$1,054,836-$785,360
AOCI$14-$60-$4,327-$1,366
Other Equity$1,855,318$1,625,637$1,558,459$1,515,210
Total Equity$250,504$287,506$499,315$728,502
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$501,020$565,299$822,720$1,129,407
Net Debt-$33,369-$29,421-$68,512-$142,086
Sana Biotechnology, Inc. (SANA) Financial Statements & Key Stats | AlphaPilot